blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3154980

EP3154980 - TETRAHYDROTRIAZOLOPYRIMIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND USES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.06.2022
Database last updated on 05.10.2024
FormerThe patent has been granted
Status updated on  02.07.2021
FormerGrant of patent is intended
Status updated on  18.02.2021
FormerExamination is in progress
Status updated on  14.12.2018
FormerRequest for examination was made
Status updated on  20.03.2017
FormerThe international publication has been made
Status updated on  09.12.2016
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024 [2024/42]
Applicant(s)For all designated states
Chiesi Farmaceutici S.p.A.
Via Palermo, 26/A
43122 Parma / IT
[2021/17]
Former [2020/27]For all designated states
Chiesi Farmaceutici S.p.A.
Via Palermo 26/A
43122 Parma / IT
Former [2017/16]For all designated states
Chiesi Farmaceutici S.p.A.
Via Palermo, 26/A
43100 Parma / IT
Inventor(s)01 / ARMANI, Elisabetta
c/o CHIESI FARMACEUTICI S.p.A.
Via Palermo 26/A
I-43100 Parma / IT
02 / CAPALDI, Carmelida
c/o CHIESI FARMACEUTICI S.p.A.
Via Palermo 26/A
I-43100 Parma / IT
03 / SUTTON, Jonathan Mark
c/o CHIESI FARMACEUTICI S.p.A.
Via Palermo 26/A
I-43100 Parma / IT
04 / HEALD, Robert Andrew
c/o CHIESI FARMACEUTICI S.p.A.
Via Palermo 26/A
I-43100 Parma / IT
 [2017/16]
Representative(s)Bianchetti & Minoja with Trevisan & Cuonzo IPS SRL
Via Plinio, 63
20129 Milano / IT
[N/P]
Former [2021/31]Bianchetti & Minoja SRL
Via Plinio, 63
20129 Milano / IT
Former [2017/16]Bianchetti Bracco Minoja S.r.l.
Via Plinio, 63
20129 Milano / IT
Application number, filing date15731865.012.06.2015
[2017/16]
WO2015EP63121
Priority number, dateEP2014017217612.06.2014         Original published format: EP 14172176
[2017/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015189362
Date:17.12.2015
Language:EN
[2015/50]
Type: A1 Application with search report 
No.:EP3154980
Date:19.04.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 17.12.2015 takes the place of the publication of the European patent application.
[2017/16]
Type: B1 Patent specification 
No.:EP3154980
Date:04.08.2021
Language:EN
[2021/31]
Search report(s)International search report - published on:EP17.12.2015
ClassificationIPC:C07D487/04, A61K31/519, A61P11/00, A61P1/00
[2017/16]
CPC:
C07D487/04 (EP,CN,KR,US); A61K31/519 (KR,US); A61K9/0053 (KR);
A61K9/007 (KR); A61P1/00 (EP); A61P11/00 (EP);
A61P11/06 (EP); A61P11/08 (EP); A61P11/14 (EP);
A61P29/00 (EP); A61P31/00 (EP); A61P35/00 (EP);
A61P37/08 (EP); A61P7/00 (EP); A61P9/14 (EP);
A61K9/0075 (EP,US); A61K9/008 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/16]
Extension statesBA09.12.2016
ME09.12.2016
Validation statesMA09.12.2016
TitleGerman:TETRAHYDROTRIAZOLOPYRIMIDINDERIVATE,DIESE VERBINDUNGEN ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN SOWIE VERWENDUNGEN[2021/09]
English:TETRAHYDROTRIAZOLOPYRIMIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND USES[2017/16]
French:DÉRIVÉS DE TÉTRAHYDROTRIAZOLOPYRIMIDINE, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT ET UTILISATIONS[2017/16]
Former [2017/16]TETRAHYDROTRIAZOLPYRIMIDINDERIVATE, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN DAMIT UND VERWENDUNGEN
Entry into regional phase09.12.2016National basic fee paid 
09.12.2016Designation fee(s) paid 
09.12.2016Examination fee paid 
Examination procedure09.12.2016Examination requested  [2017/16]
09.12.2016Date on which the examining division has become responsible
06.04.2017Amendment by applicant (claims and/or description)
13.12.2018Despatch of a communication from the examining division (Time limit: M04)
12.03.2019Reply to a communication from the examining division
09.03.2020Despatch of a communication from the examining division (Time limit: M04)
03.06.2020Reply to a communication from the examining division
19.02.2021Communication of intention to grant the patent
22.06.2021Fee for grant paid
22.06.2021Fee for publishing/printing paid
22.06.2021Receipt of the translation of the claim(s)
Opposition(s)06.05.2022No opposition filed within time limit [2022/28]
Fees paidRenewal fee
27.06.2017Renewal fee patent year 03
27.06.2018Renewal fee patent year 04
27.06.2019Renewal fee patent year 05
29.06.2020Renewal fee patent year 06
28.06.2021Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU12.06.2015
AL04.08.2021
AT04.08.2021
CY04.08.2021
CZ04.08.2021
DK04.08.2021
EE04.08.2021
ES04.08.2021
FI04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
MC04.08.2021
MK04.08.2021
MT04.08.2021
NL04.08.2021
PL04.08.2021
RO04.08.2021
RS04.08.2021
SE04.08.2021
SI04.08.2021
SK04.08.2021
SM04.08.2021
BG04.11.2021
NO04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
[2024/42]
Former [2024/22]HU12.06.2015
AL04.08.2021
AT04.08.2021
CY04.08.2021
CZ04.08.2021
DK04.08.2021
EE04.08.2021
ES04.08.2021
FI04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
MC04.08.2021
MK04.08.2021
NL04.08.2021
PL04.08.2021
RO04.08.2021
RS04.08.2021
SE04.08.2021
SI04.08.2021
SK04.08.2021
SM04.08.2021
BG04.11.2021
NO04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2024/20]HU12.06.2015
AL04.08.2021
AT04.08.2021
CY04.08.2021
CZ04.08.2021
DK04.08.2021
EE04.08.2021
ES04.08.2021
FI04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
MC04.08.2021
NL04.08.2021
PL04.08.2021
RO04.08.2021
RS04.08.2021
SE04.08.2021
SI04.08.2021
SK04.08.2021
SM04.08.2021
BG04.11.2021
NO04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2024/18]HU12.06.2015
AL04.08.2021
AT04.08.2021
CZ04.08.2021
DK04.08.2021
EE04.08.2021
ES04.08.2021
FI04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
MC04.08.2021
NL04.08.2021
PL04.08.2021
RO04.08.2021
RS04.08.2021
SE04.08.2021
SI04.08.2021
SK04.08.2021
SM04.08.2021
BG04.11.2021
NO04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2023/08]AL04.08.2021
AT04.08.2021
CZ04.08.2021
DK04.08.2021
EE04.08.2021
ES04.08.2021
FI04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
MC04.08.2021
NL04.08.2021
PL04.08.2021
RO04.08.2021
RS04.08.2021
SE04.08.2021
SI04.08.2021
SK04.08.2021
SM04.08.2021
BG04.11.2021
NO04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2022/36]AL04.08.2021
AT04.08.2021
CZ04.08.2021
DK04.08.2021
EE04.08.2021
ES04.08.2021
FI04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
NL04.08.2021
PL04.08.2021
RO04.08.2021
RS04.08.2021
SE04.08.2021
SI04.08.2021
SK04.08.2021
SM04.08.2021
BG04.11.2021
NO04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2022/29]AL04.08.2021
AT04.08.2021
CZ04.08.2021
DK04.08.2021
EE04.08.2021
ES04.08.2021
FI04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
NL04.08.2021
PL04.08.2021
RO04.08.2021
RS04.08.2021
SE04.08.2021
SK04.08.2021
SM04.08.2021
BG04.11.2021
NO04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2022/26]AT04.08.2021
CZ04.08.2021
DK04.08.2021
EE04.08.2021
ES04.08.2021
FI04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
NL04.08.2021
PL04.08.2021
RO04.08.2021
RS04.08.2021
SE04.08.2021
SK04.08.2021
SM04.08.2021
BG04.11.2021
NO04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2022/24]AT04.08.2021
CZ04.08.2021
DK04.08.2021
EE04.08.2021
ES04.08.2021
FI04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
NL04.08.2021
PL04.08.2021
RO04.08.2021
RS04.08.2021
SE04.08.2021
SK04.08.2021
BG04.11.2021
NO04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2022/21]AT04.08.2021
DK04.08.2021
ES04.08.2021
FI04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
NL04.08.2021
PL04.08.2021
RS04.08.2021
SE04.08.2021
BG04.11.2021
NO04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2022/16]AT04.08.2021
ES04.08.2021
FI04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
NL04.08.2021
PL04.08.2021
RS04.08.2021
SE04.08.2021
BG04.11.2021
NO04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2022/10]AT04.08.2021
ES04.08.2021
FI04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
PL04.08.2021
RS04.08.2021
SE04.08.2021
BG04.11.2021
NO04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2022/09]AT04.08.2021
ES04.08.2021
FI04.08.2021
LT04.08.2021
RS04.08.2021
SE04.08.2021
BG04.11.2021
NO04.11.2021
PT06.12.2021
Former [2022/08]AT04.08.2021
ES04.08.2021
FI04.08.2021
LT04.08.2021
SE04.08.2021
BG04.11.2021
NO04.11.2021
Former [2022/07]AT04.08.2021
LT04.08.2021
NO04.11.2021
Cited inInternational search[YD]WO2011110858  (PULMAGEN THERAPEUTICS INFLAMMATION LTD [GB], et al) [YD] 1-8,10-17 * schemes 1 to 11;; claims 1-13 *;
 [YD]WO2011110859  (PULMAGEN THERAPEUTICS INFLAMMATION LTD [GB], et al) [YD] 1-8,10-17 * Similar pyrimidinone derivatives; same use Distinguishing feature: R5 Disclaimer for overlap;; claims 1-14 *;
 [Y]US2013065913  (BLENCH TOBY JONATHAN [GB], et al) [Y] 1-8,10-17* Similar pyrimidinone derivatives; same use Distinguishing feature: R5 Disclaimer;; example 13; claims 1-15 *
by applicantEP0505321
 WO2011110858
 WO2011110859
 WO2014095700
    - BIETH, G., Regulation of Matrix accumulation, ACADEMIC PRESS, (1986), pages 217 - 306
    - WRIGHT, J.L. ET AL., AM. J. RESPIR. CRIT. CARE MED., (2002), vol. 166, pages 954 - 960
    - CHURG, A. ET AL., AM. J. RESPIR. CRIT. CARE MED., (2003), vol. 168, pages 199 - 207
    - THOMPSON, A.B.; DAUGHTON, D. ET AL., AM. REV. RESPIR. DIS., (1989), vol. 140, pages 1527 - 1537
    - LAURRELL, C.B.; ERIKKSON, S, SCAND. J. CLIN. INVEST., (1963), vol. 15, pages 132 - 140
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.